ARCHIVES

Letter to the Editors: Loss Of ET2 Would Be Disheartening, Member Of Study Section Says

This article is from The Cancer Letter archive.

Vol. 24 No. 07 | February 20, 1998

Download PDF Visit The Full Archive

Related Articles

ASCO, Pathologists Publish Guideline On Improving Accuracy Of HER2 Testing

December 29, 2006

International Working Group Suggests Earlier Endpoints For HPV Vaccine Trials

August 29, 2014

Dendreon Claims “Clear Hit” On Provenge, But Skeptics Await Data Presentation

April 17, 2009

40 Years Later: Doctor and Patient Reflect on the Cure

October 24, 2014

IOM, NCI Clash Over Proposed Change in Tabulating Minority Research

January 22, 1999

In a letter, ASCO reaffirms its views on oncology consolidation at FDA.

July 9, 2004